Cited by CrossRef (13)
- Mostafa Ejtehadifar, Sara Zahedi, Paula Gameiro, José Cabeçadas, Maria Gomes da Silva, Hans C. Beck, Ana Sofia Carvalho, Rune Matthiesen. Meta-Analysis of MS-Based Proteomics Studies Indicates Interferon Regulatory Factor 4 and Nucleobindin1 as Potential Prognostic and Drug Resistance Biomarkers in Diffuse Large B Cell Lymphoma. Cells 2023;12:196
- Seul Lee, Dong Hyun Kim, Sung Yong Oh, So Yeon Kim, Myeong Seok Koh, Ji Hyun Lee, Suee Lee, Sung-Hyun Kim, Jong-Young Kwak, Min Gyoung Pak, Mi Ha Ju, Hyo-Jin Kim, Jin Sook Jeong. Clinicopathologic significance of tumor microenvironment CD11c, and FOXP3 expression in diffuse large B-cell lymphoma patients receiving rituximab, cyclophosphamide, anthracycline, vincristine, and prednisone (R-CHOP) combination chemotherapy. Korean J Intern Med 2017;32:335
- Haihong Liao, Pengtao Song, Quan Qi, Yizhen Jiang, Shuwen Han, Yuefen Pan, Yulong Liu. Synchronous primary malignancy of colon cancer and mantle cell lymphoma: A case report. 2021;16:696
- Xiaokang Ke, Qingping Zhang, Pengcheng Zhu, Huihua He, Jingping Yuan, Qilin Ao. GNA13 is a new marker for germinal center-derived B cell lymphomas. Nano TransMed 2023;2:100002
- Tomohiro Kadota, Sachiko Seo, Hiroe Fuse, Genichiro Ishii, Kuniaki Itoh, Tomonori Yano, Kazuhiro Kaneko, Kunihiro Tsukasaki. Complications and outcomes in diffuse large B‐cell lymphoma with gastric lesions treated with R‐CHOP. Cancer Medicine 2019;8:982
- Robert S. Ohgami, Ryan M. Gill. Practical Gastrointestinal Pathology. 2019.
- Yuko Mishima, Yasuhito Terui, Masahiro Yokoyama, Noriko Nishimura, Kyoko Ueda, Yoshiharu Kusano, Hirofumi Yamauchi, Norihito Inoue, Anna Takahashi, Naoko Tsuyama, Yuji Mishima, Kengo Takeuchi, Kiyohiko Hatake. Bearing 19q13 aberration predicts poor prognosis in non‐germinal centre type of CD5+DLBCL. Br J Haematol 2018;183:661
- Aleksander Skulimowski, Piotr Hogendorf, Grażyna Poznańska, Piotr Smolewski, Janusz Strzelczyk, Adam Durczynski. Successful hemihepatectomy following chemotherapy for primary liver lymphoma: case report and review of literature. Pol Przegl Chir 2017;89:54
- Jingshu Meng, Chan Chang, Huaxiong Pan, Fang Zhu, Yin Xiao, Tao Liu, Xiu Nie, Gang Wu, Liling Zhang. Epidemiologic characteristics of malignant lymphoma in Hubei, China. 2018;97:e12120
- Hee Sang Hwang, Dok Hyun Yoon, Jung Yong Hong, Chan-Sik Park, Yoon Se Lee, Young Hyeh Ko, Seok Jin Kim, Won Seog Kim, Cheolwon Suh, Jooryung Huh. The cell-of-origin classification of diffuse large B cell lymphoma in a Korean population by the Lymph2Cx assay and its correlation with immunohistochemical algorithms. Ann Hematol 2018;97:2363
- Andrew Tiu, Vinicius Jorge, Peter Moussa, Djeneba Audrey Djibo, Sorab Gupta, Onder Alpdogan, Claudia Dourado. Survival Disparities of Diffuse Large B-Cell Lymphoma in a Community-Based Inner-City Cancer Center. Clinical Lymphoma Myeloma and Leukemia 2021;21:205
- Qinqiao Lai, Yan Zhao, Haiqing Yan, Hongling Peng. Advances in diagnosis, treatment and prognostic factors of gastrointestinal DLBCL. Leukemia Research 2023;135:107406
- Mélanie Juilland, Montserrat Gonzalez, Tabea Erdmann, Yara Banz, Zala Jevnikar, Stephan Hailfinger, Alexandar Tzankov, Michael Grau, Georg Lenz, Urban Novak, Margot Thome. CARMA1- and MyD88-dependent activation of Jun/ATF-type AP-1 complexes is a hallmark of ABC diffuse large B-cell lymphomas. 2016;127:1780